(PharmaNewsWire.Com, February 08, 2018 ) According to the report Asia Pacific Hemodynamic Monitoring Devices market, published by Market Data Forecast, the Market has been estimated at USD 204.60 Million in 2016 and is projected to reach USD 267.66 Million by 2021, at a CAGR of 5.52% during the forecast period from 2016 to 2021. Critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor the cardiac activity. The hemodynamic systems give information about blood pressure, blood volume and fluid balance.
The market for Hemodynamic Monitoring devices is mainly driven due to technological advancements, growth in the number of people suffering from hypertension, growing diabetes population, and rapid growth in the aging population. However, risks associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis, are challenging the growth of the hemodynamic monitoring systems market in Asia-Pacific region.
Asia-Pacific market for Hemodynamic Monitoring devices is segmented based on Product and Monitoring Market. By Product, the market is further sub-segmented into Systems and Disposables. By Monitoring type, the market is further sub-segmented into Invasive, Minimally invasive, Non-invasive. By end-users, the market is further sub-segmented into Hospitals, Cath labs, Home and Ambulatory Care. Based on products, disposables segment is estimated to account for the largest share. Based on types, the invasive monitoring systems segment is estimated to account for the largest share. Based on end users, hospitals segment is estimated to account for the largest share. All of these three segments are projected to grow at the highest CAGR during the forecast period.
Geographically, Asia-Pacific market for Hemodynamic Monitoring devices is segmented into China, India, Japan, South Korea and Australia. The Hemodynamic Monitoring Devices market in the Asia-Pacific region is projected to grow at the highest CAGR. Growth in aging population and the number of people suffering from diseases in populous countries such as India and China are the factors that are expected to offer significant growth opportunities for Hemodynamic Monitoring Systems.
Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc., Cheetah Medical Inc., Deltex Medical Group plc., Hemo Sapiens, Inc., ICU Medical, Inc., Osypka Medical GmbH, Schwarzer Cardiotek GmbH, and Tensys Medical, Inc. are the major players of Asia-Pacific Hemodynamic Monitoring Devices market.
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel, comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaboration’s with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
